Quick accesses for handicapped people

	manager of renaissance Funds
titre_site Home page

Articles & Press releases

Thursday, January 26, 2012

La gestion nomade et accessible

Download : Agefi 23012012

Tuesday, January 24, 2012

immatics presents positive Phase II results with its therapeutic cancer vaccine IMA910

Download : PR 240112

Monday, July 25, 2011

S.D. researchers testing wireless contact lens

Download : 07_2011

Tuesday, May 17, 2011

Pollen : "Notre produit permet un traitement à 5 injections"

Download : 24H 170511

Monday, March 28, 2011

Anergis closes CHF 18 million series A financing round to develop its innovative Allergy Vaccines and expands its Board of Directors

Download : Anergis PR 280311

Thursday, October 07, 2010

Symetis closes CHF 25 million financing

Download : press release 071010

Friday, September 24, 2010

Symetis reports on its trans-apical ACURATE TA™ first-in-man clinical study

Download : press release 230910

Tuesday, September 21, 2010

immatics raises €54 million to advance its late
stage clinical therapeutic cancer vaccine portfolio

Download : press release 21092010

Thursday, September 09, 2010

Sensimed AG receives International Recognitions: MD&DI 50 Companies to Watch, R&D100 and White Bull Finalist

Download : press release 080910

Thursday, September 09, 2010

Sensimed AG appoints Patrick Berdoz as Chairman of the Board of Directors

Download : press release 080910

Thursday, September 09, 2010

Sensimed AG extends oversubscribed Series B funding to CHF 18.6 Million

Download : press release 080910

Monday, September 06, 2010

The family business Schurter Retrofit AG has been sold.

Download : press release 060910

Thursday, June 24, 2010

Post-Vizepräsident leitet SolvAxis-Verwaltungsrat

Download : Bernerzeitung 230610

Friday, June 04, 2010

Une bonne PME, c'est aussi un bon conseil d'administration

Friday, June 04, 2010

Un regard extérieur est impératif

Download : Entreprise 280510

Thursday, June 03, 2010

immatics enters Collaboration with the National Cancer Institute (NCI) to Advance the Development of IMA950 for Glioblastoma.

Download : press release 020610

Tuesday, May 25, 2010

Sensimed lève 10 millions

Download : Agefi 250510

Tuesday, April 20, 2010

Sieben Fragen an Christian Waldvogel "Pensionskassen sind oft zu prozyklisch"

Download : NZZ 180410

Tuesday, February 16, 2010

immatics Enters Collaboration with Cancer Research UK to develop Multi-target Rationally Designed Therapeutic Cancer Vaccine

Download : 16feb10

Wednesday, February 03, 2010

La nouvelle opération de Vinci Capital

Download : Agefi 030210

Wednesday, February 03, 2010

SolvAxis accroît son capital pour réaliser ses ambitions

Download : Le Temps 030210

Vinci Capital - PSE-C - CH-1015 Lausanne - Tel +41 (0)21 693 92 34 - info@vincicapital.ch

Vinci Capital
PSE Bâtiment C
CH-1015 Lausanne
Tel +41 (0)21 693 92 34